Gedea Biotech

Gedea Biotech develops an antibiotic-free treatment for vaginal infections, pHyph. Today, bacterial vaginosis (BV) is treated with antibiotics, but one out of two patients have a recurrent episode of BV within 90 days of treatment. pHyph restores the pH of the vagina to its natural level (4.0‒4.5), thus facilitating the re-establishment of the normal vaginal bacterial flora, and is expected to reduce the risk of recurrent BV and fungal infections.